ELF3 and cancer: ELF3 is an important transcriptional regulator for the differentiation of the urothelium with a high mutation frequency in bladder cancer25, and histone-lysine N-methyltransferase genes (KMT2A/C/D) are among the most mutated in different cancer types26,27.